Novelix Pharmaceuticals Limited (NOVELIX.BO)
BSE · INR · Healthcare · Medical Distribution
₹60.03 (+1.40%) as of
Key statistics
- Market cap
- 1.71B
- P/E (TTM)
- 33.92
- EPS (TTM)
- 1.77
- Dividend yield
- 0.00%
- 52-week range
- 47.33 – 92.00
- Beta
- 0.25
- Revenue (TTM)
- 1.47B
- Profit margin
- 2.47%
- Volume
- 1.48k
About Novelix Pharmaceuticals Limited
Novelix Pharmaceuticals Limited manufactures and trades pharmaceutical bulk drugs and related products in activities related to healthcare research, analytics, and technology in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Headquarters
- Hyderabad, India
- Employees
- 32
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- MOTILALAMC - MON50EQUAL (MON50EQUAL.NS)
- MANGALAM ORGANICS LIMITED (MANORG.BO)
- ICICI Prudential Nifty 100 ETF (NIF100IETF.BO)
- MINAL INDUSTRIES LIMITED (MINALIND.BO)
- Jetmall Spices and Masala Limi (JETMALL.BO)
- VIPPY SPINPRO LTD. (VIPPYSP.BO)
- SAIANAND COMMERCIAL LIMITED (SAICOM.BO)
- Sadbhav Infrastructure Project (SADBHIN.BO)